Drug
5% bupivacaine
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Terminated(1)
Other(2)
Detailed Status
unknown2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
terminated133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT03796195Phase 4
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
NCT04068766Not Applicable
Efficacy of Paracervical Block in Laparoscopic Myomectomy: a Randomized Controlled Trial (PALM)
NCT03792009Not Applicable
Paracervical Block in Laparoscopic Hysterectomy
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3